简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2023-01-20 14:47 IMCAS 2023: Galderma to Share Latest Data Demonstrating High Aesthetic Improvement and Patient Satisfaction Across Its Innovative Portfolio
2023-01-20 10:09 Kaneka expands GMP manufacturing capacity for mRNA in Kaneka Eurogentec S.A.
2023-01-19 18:06 TA Announces Strategic Growth Investment in Synokem Pharmaceuticals
2023-01-19 10:38 Structure Therapeutics Appoints Industry Leaders Eric Dobmeier and Joanne Waldstreicher to its Board of Directors
2023-01-18 09:31 Servier and Taiho Oncology Present Overall Survival Data for Trifluridine/Tipiracil (LONSURF®) In Combination With Bevacizumab in Patients With Refractory Metastatic Colorectal Cancer at 2023 ASCO Gastrointestinal Cancers Symposium
2023-01-17 19:54 10 Winners of the 2023 Zayed Sustainability Prize Honoured
2023-01-17 18:41 Takeda Named Global Top Employer for Sixth Consecutive Year
2023-01-17 17:57 Mental health focus makes Boehringer Ingelheim stand out as Global Top Employer 2023
2023-01-17 14:56 JUVENESCENCE Appoints Dr Richard Marshall CBE as CEO
2023-01-16 14:19 Carbios and Novozymes Strengthen Collaboration With Long-Term Exclusive Strategic Partnership to Secure Worldwide Leadership in Biorecycling of PET
2023-01-13 14:43 Takeda’s EXKIVITY® (mobocertinib) Receives Approval from the NMPA of China, Becoming the First and Only Therapy Available for Patients with EGFR Exon20 Insertion+ NSCLC
2023-01-11 18:45 Limb Lengthening Expert Dr. Dror Paley Opens First Clinic in Middle East at UAE’s Burjeel Medical City
2023-01-11 16:05 Global talent leader WilsonHCG acquires Personify to further expand its healthcare and life sciences talent solutions
2023-01-10 16:05 New Study Evaluates the Performance of Masimo SpHb® Noninvasive Spot-Check Hemoglobin in the Emergency Department
2023-01-10 14:05 Positive Results from Single Ascending Dose Phase 1 Study of ALE.F02 Targeting Claudin-1
2023-01-10 09:48 Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies
2023-01-10 09:35 Arrowhead and Takeda Announce Topline Results from SEQUOIA Phase 2 Study of Fazirsiran in Patients with Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
2023-01-06 18:16 Organon Makes Strategic Investment in Claria Medical to Support Development of Investigational Medical Device for Minimally Invasive Hysterectomy
2023-01-06 15:09 New Study Finds That Masimo Patient SafetyNet™ Helped Clinicians Reduce CPR Events and Rates, Improve CPR Success Rate, and Reduce Hospital Length of Stay and Mortality
2023-01-06 09:21 Takeda Announces Favorable Phase 3 Safety and Efficacy Results of TAK-755 as Compared to Standard of Care in Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

Business Wire Weibo

Press Releases

Latest Releases